Category: Greatbatch Inc.Syndicate content

FTC wants more data on MDT-COV deal | Medtech Wall Street news for the week of August 11, 2014

August 14, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: FTC wants more data on Medtronic-Covidien deal, but analysts aren't worried; Greatbatch acquires Uruguay's CCC Medical Devices; T2 Biosystems IPO raises $57M for MRI-based diagnostics; Strong Q4, $750M buyback give CareFusion a boost; Baxano: Strong Q2, new patents can't appease Wall Street

FTC wants more data on Medtronic-Covidien deal, but analysts aren't worried

August 7, 2014 by Arezu Sarvestani

Analyst report: Dems can't stop Medtronic-Covidien merger

Greatbatch acquires Uruguay's CCC Medical Devices

August 12, 2014 by Brad Perriello

Greatbatch says it paid an unspecified amount for CCC Medical Devices, a Uruguay-based maker of implantable pulse generators, programmer systems, battery chargers, patient wands and leads.

Greatbatch acquires Uruguay's CCC Medical Devices

Greatbatch (NYSE:GB) said today that it paid an unspecified amount to acquire a Uruguayan medical device company.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Sunshine Heart taps Boston Scientific R&D vet for ops role | Personnel Moves

June 23, 2014 by Brad Perriello

Sunshine Heart taps ex-Boston Scientific cardiovascular R&D veteran Brian Brown as its new vice president for operations & technology.

Sunshine Heart taps Boston Scientific R&D vet for ops role | Personnel Moves

Layoffs ahead as Greatbatch transfers production to Mexico, Massachusetts

May 28, 2014 by Brad Perriello

Greatbatch says it plans to move some of its U.S. manufacturing operations to plants in Tijuana, Mexico, and from Oregon to Massachusetts.

Greatbatch to transfer some production to Mexico, Massachusetts

Greatbatch (NYSE:GB) said today that it's planning to shuffle its manufacturing operation, moving some production from Minnesota, Oregon and Massachusetts to plants in Tijuana, Mexico.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Greatbatch requests CE Mark for spinal cord stim

January 20, 2014 by Chris Walker

Greatbatch files for European CE Mark for its spinal cord stimulation system, hoping to land marketing approval the treatment of chronic pain of the trunk and limbs.

Greatbatch submits spinal cord stim for CE Mark

Greatbatch (NYSE:GB) filed a CE Mark application for its spinal cord stimulation system with German notified body TÜV SÜD America.

Greatbatch submits PMA for spinal cord stim

December 19, 2013 by Chris Walker

Greatbatch files a pre-market approval application for its spinal cord neuromodulation system for treatment of chronic pain of the trunk and limbs.

Greatbatch filing PMA for spinal cord neuromodulation system

Greatbatch (NYSE:GB) this week filed a pre-market approval application with the FDA for its spinal cord neuromodulation system.

The neuromodulation system comes from the Frisco, Texas-based company's subsidiary, QiG Group, which hopes to win indication to treat chronic pain of the trunk and limbs.

Greatbatch gains on Q3 swing to black, earnings beat

October 25, 2013 by Brad Perriello

Greatbatch swings to 3rd-quarter profits and beats Wall Street's earnings expectations, sending share prices up today.

Greatbatch gains on Q3 swing to black, earnings beat

Greatbatch (NYSE:GB) shares are up this morning after the medical device company reported a profitable 3rd quarter and beat Wall Street's expectations for per-share earnings.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp